Status:
NOT_YET_RECRUITING
VGAIT for Chemotherapy-induced Peripheral Neuropathy
Lead Sponsor:
Massachusetts General Hospital
Conditions:
Chemotherapy-induced Peripheral Neuropathy
Eligibility:
FEMALE
18-80 years
Phase:
NA
Brief Summary
Perform a feasibility study on imagined acupuncture treatment of Chemotherapy-induced peripheral neuropathy (CIPN)
Detailed Description
We will perform a pilot study to assess the feasibility of Video-Guided Acupuncture Imagery Treatment (VGAIT) on CIPN symptoms in patients with stage I-III breast cancer with persistent CIPN after adj...
Eligibility Criteria
Inclusion
- at least 18 years of age
- have histologically confirmed stage I-III breast cancer,
- have completed adjuvant taxane-based chemotherapy (alone or in combination), ,
- have an Eastern Cooperative Oncology Group performance status of 0 or 1, and reported grade 1 or greater CIPN symptoms for more than 2 weeks as defined by the National Cancer Institute (NCI) Common Terminology Criteria for Adverse Events (CTCAE), version 4.03.
Exclusion
- concurrent chemotherapy (there were no limitations on time from the last paclitaxel administration),
- having metastatic or recurrent disease,
- history of preexisting peripheral neuropathy prior to chemotherapy,
- uncontrolled seizure disorder,
- unstable cardiac disease or myocardial infarction within 6 months prior to study entry, being pregnant or nursing, or having used acupuncture for CIPN within 6 months prior to study entry.
Key Trial Info
Start Date :
November 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2026
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT07177820
Start Date
November 1 2025
End Date
December 31 2026
Last Update
September 17 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.